A transatlantic research team will investigate how obesity and metabolic disease contribute to kidney cancer risk, with the goal of identifying new prevention strategies.

Researchers are hoping a new clinical trial could delay or reduce the risk of cancer for people with a rare condition. Li-Fraumeni syndrome (LFS) can increase an individuals likelihood of developing cancer during their lifetime by about 90%.

Jazz Pharmaceuticals’ bispecific antibody Ziihera has gained an FDA approval for first-line HER2-positive stomach cancer, unlocking another market as the company builds toward a $2 billion-plus pea | Jazz’s bispecific antibody Ziihera has gained an FDA approval for first-line HER2-positive stomach cancer,

Sabina McMahon was diagnosed with osteosarcoma, a form of bone cancer, when she was 12 years old. After chemotherapy, radiation and surgery to remove the affected leg bone, she was cancer-free for more than a year,

The AACR roadmap spotlights LDCT screening, ctDNA MRD monitoring, and new NSCLC/SCLC therapies like DLL3 tarlatamab to close survival gaps. Lung cancer remains the leading cause of cancer death in the US,

Blood Cancer United, formerly The Leukemia & Lymphoma Society (LLS), the largest global nonprofit focused on serving blood cancer patients, is launching its signature community event, Light The Night,

New state-of-the-art facilities will increase patient access to specialists, clinical trials, and cutting-edge treatments across Louisiana.